Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment
Tryp Therapeutics is seeking approval from U.S. regulators for a clinical trial on psilocybin-assisted therapy to help those with irritable bowel syndrome (IBS).
May 26, 2023
Study: Personal Psychedelic Use Common Among Therapists
The practice is controversial, with some saying it is inappropriate for therapists to use psychedelic drugs.
March 1, 2023
Utah Lawmaker Files Bill To Explore Therapeutic Use of Psychedelics
In a surprising move, Utah legislators are backing a law that could lead to embracing psychedelics for therapeutic reasons.
January 21, 2022